How Does Treatment Satisfaction Work?
Open Access
- 26 May 2009
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (8), 1411-1417
- https://doi.org/10.2337/dc08-2256
Abstract
OBJECTIVE: This study tested a model hypothesizing that treatment affects objective clinical outcomes, which in turn affect perceived consequences, which in turn affect satisfaction and preference judgments. RESEARCH DESIGN AND METHODS: The model was tested in a double-blind, randomized clinical trial in which 266 patients with type 1 diabetes added active or placebo pramlintide to their insulin regimens. Objective clinical outcomes included changes in glucose and weight control, insulin requirements, incidence of hypoglycemia, and study drug tolerance. At the end of the trial, patients completed the validated PRAM-TSQ questionnaire measuring treatment satisfaction and preference and perceived medication benefits and side effects. RESULTS: Statistical modeling demonstrated that active pramlintide was significantly associated with greater treatment satisfaction, preference, and perceived benefits (all except hypoglycemia prevention), as well as objective clinical outcomes (weight loss, lower postprandial glucose [PPG], lower medication tolerance, more hypoglycemia). Perceptions of treatment consequences were sensitive and specific to their cognate objective clinical outcomes (no halo effects). Clinical outcomes (especially PPG) accounted for almost half of the effect of the study medication on treatment satisfaction and preference. Treatment satisfaction and preference were strongly related to the perceived benefits/side effects of the study medication, and these perceptions (especially glucose control) mediated most of the association of clinical outcomes with satisfaction and preference. CONCLUSIONS: This model received substantial empirical support. Improvements in objective clinical outcomes accounted for a large part of the association of pramlintide treatment with higher treatment satisfaction and preference. Perceived treatment consequences mediated the effect of objective clinical benefits on satisfaction with and preference for the study medication.This publication has 22 references indexed in Scilit:
- Psychometric Properties of an Instrument for Assessing Treatment Satisfaction Associated With Pramlintide UseThe Diabetes Educator, 2009
- Effect of Adjunctive Pramlintide Treatment on Treatment Satisfaction in Patients With Type 1 DiabetesDiabetes Care, 2007
- Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the serviceInternational Journal of Clinical Practice, 2007
- A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 DiabetesDiabetes Care, 2006
- Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trialDiabetic Medicine, 2004
- Interpretation of Changes in Health-related Quality of LifeMedical Care, 2003
- Causal Analysis: Theory and ApplicationJournal of Pediatric Psychology, 1996
- Epidemiology of severe hypoglycemia in the diabetes control and complications trialThe American Journal of Medicine, 1991
- Epidemiology of severe hypoglycemia in the diabetes control and complications trialThe American Journal of Medicine, 1991
- Ecological Correlations and the Behavior of IndividualsAmerican Sociological Review, 1950